Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. | Cell Death Dis | 2023 | 37775701 | PubTator, text mining | PubMed |
| Pancreatic Cancer and Detection Methods. | Biomedicines | 2023 | 37760999 | PubTator, text mining | PubMed |
| Long non-coding HOXA-AS3 contributes to osteosarcoma progression through the miR-1286/TEAD1 axis. | J Orthop Surg Res | 2023 | 37752588 | PubTator, text mining | PubMed |
| YAP1 affects the prognosis through the regulation of stemness in endometrial cancer. | PeerJ | 2023 | 37744228 | PubTator, text mining | PubMed |
| RORB, an Alzheimer's disease susceptibility gene, is associated with viral encephalitis, an Alzheimer's disease risk factor. | Clin Neurol Neurosurg | 2023 | 37734269 | PubTator, text mining | PubMed |
| Chloroacetamide fragment library screening identifies new scaffolds for covalent inhibition of the TEAD·YAP1 interaction. | RSC Med Chem | 2023 | 37731696 | PubTator, text mining | PubMed |
| LncRNA AP000695.2 promotes glycolysis of lung adenocarcinoma via the miR-335-3p/TEAD1 axis. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37723874 | PubTator, text mining | PubMed |
| Liquid‒liquid phase separation: roles and implications in future cancer treatment. | Int J Biol Sci | 2023 | 37705755 | PubTator, text mining | PubMed |
| Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. | Cells | 2023 | 37681853 | PubTator, text mining | PubMed |
| A Multicenter Analysis of Abnormal Chromosomal Microarray Findings in Congenital Heart Disease. | J Am Heart Assoc | 2023 | 37681527 | PubTator, text mining | PubMed |
| The HPV8 E6 protein targets the Hippo and Wnt signaling pathways as part of its arsenal to restrain keratinocyte differentiation. | mBio | 2023 | 37676018 | PubTator, text mining | PubMed |
| Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations. | Cell Death Dis | 2023 | 37673877 | PubTator, text mining | PubMed |
| The roles and therapeutic implications of messenger RNA internal N7 -methylguanosine and N6 -methyladenosine modifications in chemoresistance. | Clin Transl Med | 2023 | 37667528 | PubTator, text mining | PubMed |
| Research Progress and Molecular Mechanisms of Endothelial Cells Inflammation in Vascular-Related Diseases. | J Inflamm Res | 2023 | 37641702 | PubTator, text mining | PubMed |
| The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review. | Biomedicines | 2023 | 37626776 | PubTator, text mining | PubMed |
| Phylogenetic and Morphological Evidence Reveal Five New Species of Boletes from Southern China. | J Fungi (Basel) | 2023 | 37623585 | PubTator, text mining | PubMed |
| Advances in single-cell RNA sequencing and its applications in cancer research. | J Hematol Oncol | 2023 | 37612741 | PubTator, text mining | PubMed |
| Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration. | Pathophysiology | 2023 | 37606389 | PubTator, text mining | PubMed |
| Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD. | JCI Insight | 2023 | 37606038 | PubTator, text mining | PubMed |
The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation. | Front Genet | 2023 | 37600653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=20